Daniel Scavilla

President & CEO at Dentsply Sirona

Before to joining Dentsply Sirona as President & CEO in August 2025, Mr. Scavilla served as President and CEO of Globus Medical, Inc. (NYSE: GMED), where he led the acquisition of NuVasive, Inc. in an all-stock deal valued at $3 billion and oversaw the integration of the two organizations to create the world’s second largest spine technology company. Mr. Scavilla previously held various executive leadership positions at Globus Medical, including serving as its Chief Financial Officer and Executive Vice President, Chief Commercial Officer and President, Trauma, where he scaled the Company’s manufacturing and distribution capabilities and launched the Orthopedics and Trauma business unit. Prior to joining Globus Medical, Mr. Scavilla spent 28 years in leadership roles across different businesses at Johnson & Johnson. Notably, in his role as Chief Financial Officer, Worldwide Vice President Finance of Advanced Sterilization Products, Mr. Scavilla helped the Company’s infection prevention business to capture the top market position in Sterilization. Mr. Scavilla received a Bachelor of Science in Finance and Organizational Behavior from LaSalle University and a Master of Business Administration in International Management from Temple University.


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Dentsply Sirona

21 followers

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care.


Industries

Employees

10,000+

Links